Childhood Cancer in Peru, as a public health problerm

Descripción del Articulo

Childhood cancer in Peru poses a significant public health challenge, with a survival rate of 63.7%. Early detection, crucial for improving this rate, is hindered by access issues and late diagnoses. Symptoms such as persistent fever and abnormal lymph nodes require prompt identification. In 2018, t...

Descripción completa

Detalles Bibliográficos
Autores: Maradiegue-Chirinos, Essy Milagros, Vallejos-Gamboa, José Luis, Pascual-Morales, Claudia, Vásquez-Ponce, Liliana, Díaz-Vélez, Cristian, Peña-Sánchez, Eric Ricardo
Formato: artículo
Fecha de Publicación:2024
Institución:Fundación Instituto Hipólito Unanue
Repositorio:Diagnóstico
Lenguaje:español
OAI Identifier:oai:revistadiagnostico.fihu.org.pe:article/524
Enlace del recurso:https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/524
Nivel de acceso:acceso abierto
Materia:Oncología pediátrica
detección temprana
desigualdades en salud
inversión en salud pública
Pediatric oncology
early detection
health disparities
public health investment
id REVFIHU_fb77c4809d5bacd326c1be0113feb96c
oai_identifier_str oai:revistadiagnostico.fihu.org.pe:article/524
network_acronym_str REVFIHU
network_name_str Diagnóstico
repository_id_str
dc.title.none.fl_str_mv Childhood Cancer in Peru, as a public health problerm
El Cáncer Infantil en el Perú, como problema de salud pública
title Childhood Cancer in Peru, as a public health problerm
spellingShingle Childhood Cancer in Peru, as a public health problerm
Maradiegue-Chirinos, Essy Milagros
Oncología pediátrica
detección temprana
desigualdades en salud
inversión en salud pública
Pediatric oncology
early detection
health disparities
public health investment
title_short Childhood Cancer in Peru, as a public health problerm
title_full Childhood Cancer in Peru, as a public health problerm
title_fullStr Childhood Cancer in Peru, as a public health problerm
title_full_unstemmed Childhood Cancer in Peru, as a public health problerm
title_sort Childhood Cancer in Peru, as a public health problerm
dc.creator.none.fl_str_mv Maradiegue-Chirinos, Essy Milagros
Vallejos-Gamboa, José Luis
Pascual-Morales, Claudia
Vásquez-Ponce, Liliana
Díaz-Vélez, Cristian
Peña-Sánchez, Eric Ricardo
author Maradiegue-Chirinos, Essy Milagros
author_facet Maradiegue-Chirinos, Essy Milagros
Vallejos-Gamboa, José Luis
Pascual-Morales, Claudia
Vásquez-Ponce, Liliana
Díaz-Vélez, Cristian
Peña-Sánchez, Eric Ricardo
author_role author
author2 Vallejos-Gamboa, José Luis
Pascual-Morales, Claudia
Vásquez-Ponce, Liliana
Díaz-Vélez, Cristian
Peña-Sánchez, Eric Ricardo
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Oncología pediátrica
detección temprana
desigualdades en salud
inversión en salud pública
Pediatric oncology
early detection
health disparities
public health investment
topic Oncología pediátrica
detección temprana
desigualdades en salud
inversión en salud pública
Pediatric oncology
early detection
health disparities
public health investment
description Childhood cancer in Peru poses a significant public health challenge, with a survival rate of 63.7%. Early detection, crucial for improving this rate, is hindered by access issues and late diagnoses. Symptoms such as persistent fever and abnormal lymph nodes require prompt identification. In 2018, the WHO, in collaboration with St. Jude Children's Research Hospital and the International Society of Paediatric Oncology, launched the Global Initiative for Childhood Cancer, aiming for a 60% survival rate by 2030. Peru, designated as a focal country in 2019, has implemented the CURE ALL technical package, focusing on centers of excellence, universal coverage, treatment regimens, and continuous evaluation. Despite advancements in infrastructure and training, challenges remain. The centralization of services in Lima complicates access for rural regions, and the fragmented healthcare system exacerbates the situation. Public health investment needs to be increased, standing at 3.95% of GDP, compared to the 6% recommended by the OECD. Laws such as the Childhood Cancer Law and the National Cancer Law have improved coverage and access to treatments, but sustained investment and a multisectoral approach are needed to reduce disparities and improve survival rates. Collaboration between institutions and the adoption of innovative technologies are key to advancing childhood cancer care in Peru.
publishDate 2024
dc.date.none.fl_str_mv 2024-08-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/524
10.33734/diagnostico.v63i2.524
url https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/524
identifier_str_mv 10.33734/diagnostico.v63i2.524
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/524/500
dc.rights.none.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
dc.source.none.fl_str_mv Diagnóstico; Vol. 63 No. 2 (2024); e524
Diagnostico; Vol. 63 Núm. 2 (2024); e524
1018-2888
2709-7951
10.33734/diagnostico.v63i2
reponame:Diagnóstico
instname:Fundación Instituto Hipólito Unanue
instacron:FIHU
instname_str Fundación Instituto Hipólito Unanue
instacron_str FIHU
institution FIHU
reponame_str Diagnóstico
collection Diagnóstico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1846524449753399296
spelling Childhood Cancer in Peru, as a public health problermEl Cáncer Infantil en el Perú, como problema de salud públicaMaradiegue-Chirinos, Essy MilagrosVallejos-Gamboa, José LuisPascual-Morales, ClaudiaVásquez-Ponce, LilianaDíaz-Vélez, CristianPeña-Sánchez, Eric RicardoOncología pediátricadetección tempranadesigualdades en saludinversión en salud públicaPediatric oncologyearly detectionhealth disparitiespublic health investmentChildhood cancer in Peru poses a significant public health challenge, with a survival rate of 63.7%. Early detection, crucial for improving this rate, is hindered by access issues and late diagnoses. Symptoms such as persistent fever and abnormal lymph nodes require prompt identification. In 2018, the WHO, in collaboration with St. Jude Children's Research Hospital and the International Society of Paediatric Oncology, launched the Global Initiative for Childhood Cancer, aiming for a 60% survival rate by 2030. Peru, designated as a focal country in 2019, has implemented the CURE ALL technical package, focusing on centers of excellence, universal coverage, treatment regimens, and continuous evaluation. Despite advancements in infrastructure and training, challenges remain. The centralization of services in Lima complicates access for rural regions, and the fragmented healthcare system exacerbates the situation. Public health investment needs to be increased, standing at 3.95% of GDP, compared to the 6% recommended by the OECD. Laws such as the Childhood Cancer Law and the National Cancer Law have improved coverage and access to treatments, but sustained investment and a multisectoral approach are needed to reduce disparities and improve survival rates. Collaboration between institutions and the adoption of innovative technologies are key to advancing childhood cancer care in Peru.El cáncer infantil en Perú es un reto significativo en salud pública, con una tasa de supervivencia del 63.7%. La detección precoz, esencial para mejorar esta tasa, se dificulta por problemas de acceso y diagnóstico tardío. Síntomas como fiebre persistente y ganglios anormales requieren identificación rápida. En 2018, la OMS, junto a St. Jude Children's Research Hospital y la Sociedad Internacional de Oncología Pediátrica, lanzó la Iniciativa Global contra el Cáncer Infantil, buscando una tasa de supervivencia del 60% para 2030. Perú, como país focal desde 2019, ha implementado el paquete técnico CURE ALL, centrado en centros de excelencia, cobertura universal, regímenes de tratamiento y evaluación continua. A pesar de avances en infraestructura y capacitación, persisten desafíos. La centralización de servicios en Lima complica el acceso para regiones rurales, y la fragmentación del sistema de salud agrava la situación. La inversión en salud pública es insuficiente, situándose en 3.95% del PBI, frente al 6% recomendado por la OCDE. Leyes como la ley de cáncer infantil y ley nacional de cáncer, han mejorado la cobertura y acceso a tratamientos, pero se necesita una inversión sostenida y un enfoque multisectorial para reducir disparidades y mejorar las tasas de supervivencia. La colaboración entre instituciones y la adopción de tecnologías innovadoras son claves para avanzar en la atención del cáncer infantil en el Perú.Fundación Instituto Hipólito Unanue2024-08-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/52410.33734/diagnostico.v63i2.524Diagnóstico; Vol. 63 No. 2 (2024); e524Diagnostico; Vol. 63 Núm. 2 (2024); e5241018-28882709-795110.33734/diagnostico.v63i2reponame:Diagnósticoinstname:Fundación Instituto Hipólito Unanueinstacron:FIHUspahttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/524/500Derechos de autor 2024 Essy Milagros Maradiegue-Chirinos, José Luis Vallejos-Gamboa, Claudia Pascual-Morales, Liliana Vásquez-Ponce, Cristian Díaz-Vélez, Eric Ricardo Peña-Sánchezhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:revistadiagnostico.fihu.org.pe:article/5242024-08-23T01:20:24Z
score 13.413352
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).